What is Exagen Inc.'s stock-based comp?

Exagen Inc. (XGN) reported stock-based comp of $655K in Q1 2026.

How has Exagen Inc.'s stock-based comp changed year-over-year?

Exagen Inc.'s stock-based comp increased by 57.1% year-over-year, from $417K to $655K.

What is the long-term trend for Exagen Inc.'s stock-based comp?

Over 4 years (2021 to 2025), Exagen Inc.'s stock-based comp has grown at a -17.8% compound annual growth rate (CAGR), from $4.73M to $2.16M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Exagen Inc. XGN Stock-Based Comp

Stock-Based Comp at other companies

Labcorp HoldingsLH

$31.7M-3.4%

Quest DiagnosticsDGX

$20M-9.1%

Vor BiopharmaVOR

$8.87M+359%

Avalo TherapeuticsAVTX

$3.58M+10.3%

CareDxCDNA

$9.8M+9.8%

RevvityRVTY

$8.72M+12.7%

Segments

By segment

See full

Reportable Segment$607K+67.7%

Other financials

Income statement

See full

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

See full

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total equity$14.4M+125%

Total assets$52.0M+28.9%

Cash flow

See full

Operating cash flow-$10.4M+2.4%

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

See full

Market cap$112.34M-26.5%

Enterprise value$117.78M-20.3%

P/S1.6×-1.0×

Profitability

See full

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s stock-based comp?: Exagen Inc. (XGN) reported stock-based comp of $655K in Q1 2026.
How has Exagen Inc.'s stock-based comp changed year-over-year?: Exagen Inc.'s stock-based comp increased by 57.1% year-over-year, from $417K to $655K.
What is the long-term trend for Exagen Inc.'s stock-based comp?: Over 4 years (2021 to 2025), Exagen Inc.'s stock-based comp has grown at a -17.8% compound annual growth rate (CAGR), from $4.73M to $2.16M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.